UBS Maintains Neutral on Ingredion, Raises Price Target to $108

Ingredion Announces Appointment Of Diego Reynoso As CFO Effective October 1

Ingredion Incorporated 公佈 2026 年第二季度業績

Ingredion Incorporated reported Q2 2026 results with reported diluted EPS of $1.78 and adjusted EPS of $2.82, down from $2.99 and $2.87 respectively in Q2 2025. Net sales increased 1% to $1.85 billion, while adjusted operating income declined 5%. The company completed the sale of its Pakistan business majority stake and announced that Tate & Lyle shareholders approved its 595 pence all-cash acquisition offer. Ingredion reaffirmed full-year 2026 guidance with reported EPS of $9.15-$9.75 and adjusted EPS of $10.30-$10.90.

Ingredion Incorporated 公布 2026 年第二季度业绩

Ingredion Incorporated reported Q2 2026 results with reported diluted EPS of $1.78 versus $2.99 in Q2 2025, representing a 40% decline. The company reaffirmed full-year 2026 guidance with adjusted EPS expected between $10.30-$10.90. Notably, Tate & Lyle shareholders approved Ingredion's £595 pence per share all-cash acquisition offer on July 28, 2026, marking a significant step toward completing the transaction.

Ingredion, 2026년 2분기 견조한 실적 발표

Ingredion Incorporated reported Q2 2026 results showing a 31% decline in reported operating income and 5% decline in adjusted operating income year-over-year, with diluted EPS of $1.78 (reported) and $2.82 (adjusted). The company successfully sold a majority stake in its Pakistan business and received shareholder approval from Tate & Lyle for its 595 pence all-cash acquisition offer. Despite operational challenges at the Argo plant, the Texture & Healthful Solutions segment showed nine consecutive quarters of net volume growth. Full-year 2026 guidance was maintained with expected reported EPS of $9.15-$9.75 and adjusted EPS of $10.30-$10.90.